RAD51 inhibitor B02,
1290541-46-6,
B02,
(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one,
MLS000709026,
3-benzyl-2-[(E)-2-pyridin-3-ylethenyl]quinazolin-4-one,
SMR000289793,
3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone,
AC1NWXHW,
CHEMBL1567670,
RAD51 Inhibitor B02; BO2,
SCHEMBL14358385,
BDBM48804,
CHEBI:94303,
cid_5738263,
HMS2612I15,
BCP19688,
EX-A2491,
ZINC4537641,
MFCD03294274,
s8434,
STK856883,
AKOS000590396,
CS-6351,
B-02,
BAS 06058858,
HY-101462,
TX-016684,
RAD51 Inhibitor B02, >=98% (HPLC),
J3.623.048G,
MLS-0285273.0001,
SR-01000722866,
SR-01000722866-2,
3-benzyl-2-[(E)-2-(3-pyridyl)vinyl]quinazolin-4-one,
3-Benzyl-2-(2-pyridin-3-yl-vinyl)-3H-quinazolin-4-one,
3-(phenylmethyl)-2-[(E)-2-(3-pyridinyl)ethenyl]-4-quinazolinone,
3-(phenylmethyl)-2-[(E)-2-pyridin-3-ylethenyl]quinazolin-4-one,
3-benzyl-2-[(E)-2-(pyridin-3-yl)ethenyl]quinazolin-4(3H)-one,
ZINC04537641,
CID5738263,